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Abstract
Background: Current clinical guidelines recommend conservative management including non-pharmacologic
therapy prior to considering surgery for knee OA. There is a paucity of clinical trials investigating the use of
biomechanical device therapies on those with patellofemoral joint osteoarthritis (PFJOA). The aim was to
systematically review the effectiveness of biomechanical devices (bracing, taping, and footwear) in the
management of symptomatic PFJOA.
Method: The Cochrane, PEDro, MEDLINE, CINAHL, AMED and EMBASE electronic databases were search from
inception to October 31, 2020. Included studies were randomised controlled or clinical trials studying any form of
biomechanical device therapy in the management of PFJOA in the English language. Studies included in the search
were quality-appraised using the PEDro scoring system.
Result: Eleven studies were identified which included assessment of either patellar taping, or foot orthotics, knee
bracing or combined physiotherapy treatments. Trial quality ranged from ‘poor’ through ‘fair’ to ‘good’. For patellar
bracing, pooled analysis of two good quality randomised controlled trials showed no overall significant
improvement on a visual analogue scale (VAS) (random effects (RE) standardised mean difference (SMD) = −0.42
(95%CI −1.12 to +0.29).
Pooled data from the same two studies showed a non-significant improvement in favour of bracing assessed by
the KOOS/WOMAC (RE SMD = −0.18 (95%CI −0.66 to +0.31). Two studies of ‘fair’ and ‘good’ quality applying
patellar tape showed a significant reduction in pain immediately after application and after 4 days. A randomised
trial of a foot orthotic showed a non-significant improvement in pain after 6 weeks with a between groups
adjusted mean difference for maximum VAS of 21.9 mm (95% CI − 2.1 to 46.0) and 8.1 (95% CI− 6.9 to 23.1) for
KOOS pain. A multimodal physiotherapy intervention (which included taping in two studies) showed a pooled
significant improvement in VAS (SMD = −0.4; (95% CI −0.71 to −0.09) at 3 months compared to controls.
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Conclusion: There is some good quality evidence that a combined physiotherapy approach significantly reduces
short-term pain in those with PFJOA. Long-term effects of all interventions are still unknown, which indicates the
need for further research to determine the longer term impact of all biomechanical devices on outcomes in
symptomatic PFJOA.
Background
The patellofemoral joint (PFJ) is an important source of
symptoms in knee osteoarthritis (OA) compared to the
tibiofemoral joint (TFJ). In symptomatic knee OA co-
horts, the prevalence of radiographic PFJOA is 57% and
in radiographic and symptomatic knee OA cohorts the
prevalence of PFJOA is 43% [1]. Typical features of
PFJOA are anterior knee pain or retro-patella pain ag-
gravated with PFJ loading activities such as stair ambula-
tion, squatting, kneeling or rising from sitting. PFJOA
symptom management by conservative treatment is crit-
ical [2]. Altered mechanics and increased PFJ stress are
thought to be involved in the progression of PFJOA [3].
Therefore, patellar bracing and patellar taping (in which
medical or sports tape is applied either onto or around
the patella) have been suggested as interventions which
alter patella position in the trochlea, reduce PFJ stress
and limit structural damage [4]. Bracing has the advan-
tage of being easier to self-apply than taping without
loosening [5].
Current guidelines in the UK, Europe and America
recommend surgery for knee OA only after conservative
management including pharmacologic and non-
pharmacologic therapy has been exhausted [6–9].
Biomechanical device therapy, which includes taping,
bracing and modified footwear with orthotics, insoles or
inserts, is appealing as it is not linked with any of the
systemic adverse effects associated with pharmacological
therapy. There are a paucity of clinical trials to support
or refute the use of various biomechanical device therap-
ies for the management of PFJOA with a greater number
of clinical trials and systematic reviews focused on TFJ
OA [10]. Such data are important to inform optimum
clinical practice for this large, symptomatic patient sub-
group. An international consensus statement on PFJOA
produced a narrative review which implied further need
to evaluate treatment outcomes in people with PFJOA
[11]. Our aim was to undertake a systematic review with
meta-analysis of the efficacy of biomechanical device
therapies in the management of PFJOA.
Methods
Search strategy
The MEDLINE, AMED, EMBASE, CINAHL and
Cochrane Database of Systematic Reviews electronic bib-
liographic databases were searched from inception to
October 31, 2020. The search strategy and search terms
are presented in the supplementary file. Search terms
were adapted to the requirements of each specific data-
base. Where the full text was obtained, reference lists
were searched. Inclusion criteria were English language,
peer reviewed, original research, randomised controlled
or clinical trials studying biomechanical device therapy
(brace, taping and modified footwear including shoe in-
serts, insoles or foot orthotics) in the management of
PFJOA, with validated outcome measures. Exclusion cri-
teria included studies where subjects did not have pre-
dominant PFJOA, systematic and narrative reviews,
clinical commentaries, editorials or studies from non-
peer reviewed journals. Reference lists of the full-text
articles were also checked to ensure any articles not cap-
tured in the electronic search were included. We
searched the grey literature guided by the ‘Grey Matters’
checklist (Grey Matters: a practical tool for searching
health-related grey literature (https://www.cadth.ca/
resources/finding-evidence). The grey literature search
included a search of clinical trial registries (Cochrane
Central Register of Controlled Trials with ClinicalTrials.
gov) Google Scholar, and forward searches of SCOPUS/
Web of Science for all included articles as well as
searching of the reference lists of included articles and
related systematic reviews.
Assessment of study quality
One author (EP) initially independently checked the ti-
tles and abstracts of the articles against the inclusion
and exclusion criteria. Non-eligible studies were ex-
cluded. The methodological quality of full texts was in-
dependently assessed by two authors (EP and MJC)
using the Physiotherapy Evidence Database critical ap-
praisal tool (PEDro http://www.pedro.org.au). Trials
were awarded one point if each criterion was clearly sat-
isfied. Criterion 1 was not included in the final PEDro
score, so each study had a possible maximum score of
10. We considered total PEDro scores of 0–3 as ‘poor’,
4–5 as ‘fair’, 6–8 as ‘good’, and 9–10 as ‘excellent’ [12].
Any discrepancies in the appraisal scores were resolved
by discussion and consensus, after which an agreed score
was allocated (Table 1).
Data extraction
The study design, sample size, exclusion and inclusion
criteria, participant characteristics including age, BMI
and sex were extracted from the studies. Data extracted
Callaghan et al. Systematic Reviews          (2021) 10:173 Page 2 of 13
to measure the effect of the devices were from visual
analog scales (VAS) and numerical rating scales (NRS),
specific outcome tools (KOOS, WOMAC), the perceived
global rating of change (GRoC), and biomechanical data
from knee joint position and muscle strength. Addition-
ally, details on the type and frequency of intervention,
comparators and outcomes were collected and recorded
by one author (EP) and checked independently by a sec-
ond (MJC).
Statistical analysis
For each analysis, statistical heterogeneity was evaluated
using the inconsistency value (I2). An I2 of 75% and
above was interpreted as high heterogeneity [24]. A
random-effects meta-analysis was adopted for all con-
tinuous data outcomes. All analyses were conducted
using RevMan v.5.3.5 software (The Nordic Cochrane




The combined search from all of the databases produced
167 articles and following removal of duplicates and
conference abstracts, 115 articles remained. 99 articles
were discarded based on the title or the abstract alone.
From the remaining 16 full texts, another five articles
were excluded. Two were excluded as the participants
were not randomly allocated to a brace condition [5, 25],
two others because the participants either did not have
PFJOA [26], or had TFJOA rather than PFJOA [27, 28].
There were no additional articles found from the refer-
ence list of the full-text articles (see Fig. 1).
Methodological quality of the included studies
A total of eleven randomised clinical trials were assessed
for methodological quality. The PEDro scores are de-
tailed in Table 1. Nine studies were classed as ‘good’
quality, one was classed as ‘fair’ quality, and one was
classed as ‘poor’ quality.
Study characteristics
The eleven randomised clinical trials had a total of 658
knees with predominant or isolated symptomatic PFJOA.
Two studies ([14] (n=30) [15]; (n=106)) assessed some of
the participants from a parent trial ([13], n=126). Tan
et al. [23] was a biomechanical study nested within a
pilot RCT [22]. Two studies did not provide information
on the sex of the participants (Kumar & Ganesh 2011
[20];), so excluding these, the overall percentage of fe-
males (62%) was greater than males though there was
wide variation in the proportion of males and females
between the studies (males 14–45% and females 55–
86%). The mean age of participants was 53 years (range
55–70 years), and the mean BMI was 28.9kg/m2 (range
27.6–31kg/m2), with one study not providing partici-
pants’ ages [20]. Radiographic knee OA was assessed
and described in eight studies all of which used axial
(skyline) plain radiographs as a means of identifying par-
ticipants with either isolated PFJOA or OA that was
more severe in the PFJ than the TFJ. Three studies [13–
15] included subjects with Kellgren and Lawrence (K-L)
scores of grade 2 or 3 in the PFJ, which was greater than
the K-L grade for the TFJ, and excluded those whose K-
L grade was greater in the TFJ. Those with K-L scores
equal in all compartments were included if the signs and
symptoms were predominantly in the PFJOA. Two stud-
ies [16, 17] used the disease severity based on the Osteo-
arthritis Research Society International (OARSI) Atlas
for Radioanatomic Positioning of the Knee. Both studies
included radiographic evidence of either an osteophyte
of severity grade equal to or greater than 2, or joint
space narrowing (JSN) of 1 with concurrent grade 1
osteophyte(s), in the PFJ on skyline radiograph. They ex-
cluded individuals with medial more than lateral PFJ
osteophytes or with a K-L grade greater than 2 in the
TFJ. Quilty et al. [21] included those with K-L grading
grade 3 or with greater osteophytes in the PFJ and the
absence of K-L grade 3 or 4 TFJ involvement. [19] used
the OARSI atlas to assess JSN and osteophytes. PFJOA
was defined as an osteophyte or JSN of grade 2 or
greater. Those with concomitant TFJOA were not ex-
cluded if symptoms were predominantly PFJOA. Cush-
naghan et al. [18] had participants with radiographic
Table 1 Summary of the PEDro appraisal criteria for all none
studies
PEDRO criteria
Studies 1 2 3 4 5 6 7 8 9 10 11 PEDro Score
[13] X X X X X X X X X 8
[14] X X X X X X X X 7
[15] X X X X X X X 6
[16] X X X X X X X 6
[17] X X X X X X X X X 8
[18] X X X X X X 6
[19] X X X X X X X X X 8
[20] X X X 2
[21] X X X X X X X X X 8
[22] X X X X X X X X X 8
[23] X X X X X X X X X 8
Key: X: point awarded when a PEDro criterion was clearly satisfied. Note –
item 1 (eligibility criterion) is not included in the overall PEDro score
The number corresponds to the following PEDro criteria: 1=Eligibility criteria
stated, 2=Random allocation, 3=Concealed allocation, 4=Baseline
comparability, 5=Blinded subjects, 6=Blinded therapists, 7=Blinded assessors,
8= at least 85% follow-up, 9=Intention-to-treat analysis, 10=Between group
statistical analysis, 11=Point measures and measures of variability
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evidence of PFJOA (defined as definite joint space nar-
rowing with osteophytosis) predominating in the lateral
PFJ facet in all 12 patients with radiographic TFJOA also
present in those patients. Kumar & Ganesh [20] stated
that their participants were radiologically diagnosed as
patellofemoral arthritis, but provide no details of the
radiographic technique used. Two studies [22, 23] used
NICE clinical guidelines which stipulated that imaging
was not required for a clinical diagnosis of OA. One
study did not report level of symptoms [21].
All studies identified their recruitment sources. Four
recruited from primary care practitioners, hospital
physiotherapy departments or from patients’ self-referral
through adverts [13–15, 20]. Quilty et al. [21] recruited
from a large established community cohort study.
Crossley et al. [17] recruited solely from primary care
physiotherapy practices. Cushnaghan et al. [18] recruited
from a hospital rheumatology clinic. Hunter et al. [19]
and Crossley et al. [16] both stated they recruited from
the community but did not provide further details. Tan
et al. [22, 23] recruited via print media in a variety of lo-
cations such as pharmacies, community notice boards,
doctors’ surgeries, and allied health professionals’ clinics.
Randomisation and concealment
Sealed opaque envelopes were used to randomise sub-
jects in three studies [13–15]. Five trials used computer-
generated randomisation [17, 19–23]. Two studies did
not provide information that their groups were balanced
at baseline with respect to the main confounding
Fig. 1 PRISMA diagram
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variables [18, 20]. Five studies used concealed allocation;
the other studies did not (Table 1).
Intention-to-treat analysis
Intention-to-treat analysis was performed in five studies.
The crossover design studies [14, 15] had no dropouts as
well as those of within subjects design [16, 18, 23]. As all
participants completed these studies, a point was allo-
cated in the PEDro score in this criterion. Communica-
tion with the lead author in the Crossley et al. [16] study
clarified that all 14 participants completed their study
[22]. had no dropouts after 6 weeks, but excluded 2 par-
ticipants in the case-complete analysis.
Blinding
Due to the inherent nature of all the included studies, it
was not possible to blind therapists to treatment alloca-
tion. Additionally, only three studies had participants
blinded to the treatment groups [17, 19, 22]. In the eight
other studies, blinding of the participants was not pos-
sible and it is likely they were able to distinguish be-
tween the interventions. The assessors were blinded to
group allocation in seven out of the eleven studies which
would mitigate against, though not exclude the possibil-
ity of bias.
Interventions
The interventions used in the trials were bracing (n =4),
taping (n= 2), foot orthoses (n=2), and a multimodal
treatment package (which included exercises and taping)
delivered by a physiotherapist (n =3). Details of the in-
cluded studies are outlined in Table 2.
Taping interventions
The effects of patellar taping were assessed by a trial of
good quality [16] and fair quality [18]. Both had cross-
sectional designs studying the immediate or very short-
term effects only. Crossley et al. [16] compared 14
PFJOA patients with 14 healthy subjects. For the pur-
pose of this review, we extracted the within-subjects’
data for tape versus no-tape in the PFJOA group only, as
there was no comparison between those with PFJOA
and the healthy control group. The intervention was two
pieces of rigid sports tape that applied pressure to direct
the patellar medially and superiorly. Another two pieces
of tape were applied distal to the patella to unload the
infrapatellar fat pad. The tape was applied for 1-day test-
ing only. Compared to no tape, taping significantly chan-
ged patella lateral displacement (2.94% 95%CI: 0.37 to
5.51, p=0.028) and patellar lateral tilt angle (−3.57°
(95%CI: 2.14 to 4.19, p<0.001). The difference between
tape and no tape in mean VAS pain score immediately
after performing a single-leg squat was −15.3mm (95%CI
0.4 to 30, p=0.045); this was a statistically and clinically
meaningful decrease in pain within subjects with PFJOA.
Cushnaghan et al. [18] pulled a strip of rigid sports
tape across the patellar medially and compared this to
lateral directed tape and then to a piece of tape put
across the patella with no directional pull (neutral). After
4 days of treatment, there was a clinically meaningful
and statistically significant reduction of pain for medial
directed taping compared to lateral or neutral taping
(mean difference neutral v medial tape = 15.5 (95%CI
2.4 to 28.6), but not for neutral v lateral tape = −8 (95%
CI −22.5 to +6.5).
Bracing interventions
Four studies assessed the effect of bracing. A rando-
mised crossover trial [19] compared the effects of two 6-
week periods of brace wearing with and without a rea-
ligning patella strap in 67 participants with PFJOA. The
daily average self-reported time for brace wearing for ei-
ther brace was between 4.3 and 4.8 h. There was no sig-
nificant difference between brace with and without the
strap in reduction in VAS pain (0.7, 95% CI: −6.2 to 4.8;
p= 0.81) nor in WOMAC pain (−0.11, 95%CI: −0.66 to
0.88; p = 0.77), stiffness (−0.11, 95% CI: −0.53 to 0.32;
p= 0.61) or function (−0.02, 95% CI: −2.83 to 2.79; p=
0.99) for the two treatment periods.
Callaghan et al. [13] performed a 6-week RCT to
examine the effects of bracing versus no bracing on bone
marrow lesions (BML) and pain in 126 PFJOA patients.
The daily average self-reported brace wearing time was
7.4 h. The brace group experienced a clinically and sta-
tistically significant decrease in VAS for a nominated ag-
gravating activity (−13mm, 95%CI: −20 to −7; p<0.001)
and reduction in BML volume in the PFJ compartment
on magnetic resonance imaging (MRI) −490.6mm3 (95%
CI: −929.5 to −51.7) (p=0.03). Although both trials used
the same outcome after the same 6-week period of brace
wearing, there was evidence of heterogeneity of the trials
for the VAS (I2 = 83%, p = 0.02). The data were pooled
using a random effects model of the standardised mean
difference and showed no overall statistically and clinic-
ally significant benefit on a visual analogue scale (VAS)
(standardised mean difference (SMD) = −0.42 (95%CI
−1.12 to +0.29; Fig. 2). For the same two trials, the
KOOS pain and Western Ontario and McMasters
(WOMAC) were not significantly improved by bracing
(SMD −0.18: 95%CI −0.66 to 0.31; Fig. 3).
Two further studies used data from the latter trial to
look at the effect of bracing on quadriceps muscle
strength and inhibition [15] and patellofemoral align-
ment [14]. There was a significant reduction in muscle
inhibition in the brace group compared to no brace at 6
weeks (n = 106 between-group difference, −8.62%;
95%CI: −13.90% to −3.33%; p=0.002) with no significant
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change in quadriceps strength [15]. A further 30 patients
from the same cohort were randomised to brace and no
brace to assess the effect on structural patellofemoral pa-
rameters, using weight bearing MRIs to assess patellar
position and patellofemoral alignment [14]. The applica-
tion of a brace compared to no brace significantly in-
creased PFJ lateral contact area (n = 30 within subjects
difference 0.94cm2 95% CI 0.07 to 1.81, p=0.04) and re-
duced PFJ lateral distance on weight bearing MRI (n =
30 within subjects difference 0.06cm 95% CI 0.12 to
0.01, p=0.03) which was assumed to reduce patellofe-
moral contact stresses.
Foot orthotics interventions
Two good quality studies by the same research group
examined the effects of foot orthotics on painful PFJOA.
A RCT [22] compared a commercially available foot
orthotic to a flat insert sham. The purpose of this trial
was to provide feasibility information on sample size, re-
cruitment for a full scale trial. The active intervention
orthotic fitted inside the shoes had a 6° varus wedge with
a medial arch support. After 6 weeks both groups re-
ported improvements in pain and function. The foot
orthotic group demonstrated a greater but non-
significant improvement in mean change in maximum
and average pain severity on a VAS during the most ag-
gravating activity (of either ‘rising from sitting’, ‘stair am-
bulation’, or ‘squatting’) in the previous week (maximum
VAS 21.9mm (95%CI: −2.1 to 46.0); average VAS
15.8mm (95% CI − 4.9 to 36.6)). Although not statisti-
cally significant, the between groups VAS scores
exceeded the minimal clinically important difference for
chronic musculoskeletal pain. The Knee injury and
Osteoarthritis Outcome Score - activities of daily living
(KOOS-ADL) subscale was significantly improved in the
foot orthotic group compared to the sham group (13.7;
95% CI 0.2 to 27.2). There were no significant between
groups adjusted mean differences in the other KOOS
subscales (Table 2) including KOOS pain (8.1; 95% CI:
−6.9 to 23.1). The second good quality trial [23] com-
pared the immediate effects of foot orthotics and flat
sham inserts on lower limb biomechanics, knee pain and
confidence in individuals with PFJOA. For the immedi-
ate effect on VAS knee pain, there were no statistically
or clinically significant differences between the foot
orthotic and the sham insert during level walking
(4.2mm, 95% CI −2.9 to 11.2), during stair ascent
(−3.4mm, 95% CI −13.1 to 6.3) or during stair descent
(0.7mm, 95% CI −11.5 to 12.9).
Multimodal physiotherapy interventions
Three RCTs studied the effects of multimodal treatment
programmes delivered by physiotherapists in patients
with PFJOA. The study quality ranges from good [17,
21] to poor [20]. Quilty et al. [21] compared the effect
on pain and function of a combination of exercises, pa-
tella taping, posture and footwear advice (9 sessions, 30-
min duration over 10 weeks) with a control group.
Those randomised to the control group were not in-
formed that they were in a trial. At the baseline visit, pa-
tients in both the intervention and control groups had a
half-hour discussion with a physiotherapist concerning
diagnosis, prognosis, footwear, weight reduction and ac-
tivity. General exercise was encouraged but no specific
quadriceps exercises were advised. Kumar and Ganesh
[20] gave all participants the electrical therapy modality














Abbreviations: AMI arthrogenous muscle inhibition, MRI magnetic resonance imaging, OA osteoarthritis, PFJ patellofemoral joint, BMI body mass index, MVC
maximum voluntary contraction, GRoC perceived global rating of change, SD standard deviation, K-L Kellgren-Lawrence, VAS visual analogue scale, KOOS-(ADL)
knee injury and osteoarthritis outcome score (Activities of Daily Living), WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, M males, F
females, KOOS QoL knee injury and osteoarthritis outcome score (Quality of Life), NICE National Institute for Clinical Excellence
Fig. 2 VAS for brace trials versus controls
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of short wave diathermy, combined with joint mobilisa-
tions and isometric exercises. One group was randomly
assigned to medial patellar taping and the second group
to lateral patellar taping. The shortwave diathermy was
applied for 20 min daily, but further details of the set-
tings are not provided. The isometric exercises were to
the quadriceps in supine, maintained for 6 s and re-
peated for 10 times with 10 s rest between each repeti-
tion. The taping technique was described as displacing
the patella medially or laterally using manual pressure
and then maintained in this position by tape across the
middle of the patella using light to moderate pressure.
Data for the taping intervention could not be extracted
for separate analysis. Crossley et al. [17] compared com-
bined exercises, patella taping, manual therapy and edu-
cation with a control group of education only single-
patient sessions, designed to control for the patient ther-
apist interaction and psychosocial contact inherent with
the PFJ-specific combined physiotherapy treatment (8
sessions, 60-min duration over 12 weeks).
Quilty et al. [21] found no significant between
groups difference in disability on the WOMAC func-
tion subscale after 5 months. Kumar and Ganesh [20]
described the analysis for WOMAC between group A
and group B after 9 months as highly significant (p=
0.0001), but did not provide any further details such
as means and variance. There was no reference to the
clinical significance of the outcome. Crossley et al.
[17] noted no significant between groups improve-
ment in the KOOS-ADL.
Quilty et al. [21] found no statistically or clinically sig-
nificant reduction in average ‘pain during the previous
month’ (VAS −6.4mm) at 5 months. Crossley et al. [17]
recorded a clinically meaningful and significant between
groups mean reduction in ‘pain during an aggravating
activity’ (VAS −15.2mm) at 3 months.
Pooling the data from the two good quality trials
which used taping, with a random effects standardised
mean difference, there appeared to be evidence of a
small overall beneficial effect of the intervention for the
VAS (−0.41 95%CI: −0.71 to −0.09; Fig. 4).
Discussion
Overall this systematic review found good quality evi-
dence that a combined physiotherapy approach may
cause a reduction in patellofemoral pain. It is clear that
more robust trials are needed to better define the role of
these therapies as well as bracing, taping and foot or-
thotics in the management of symptomatic PFJOA. The
consistent flaws in the good quality trials were the lack
of blinding of the therapists in all the trials and the lack
of blinding of the participants in all but two trials.
A greater number of participants in the reviewed trials
were women. This is consistent with data concerning
the frequency of PFJOA in the general population. There
are no standardised clinical methods used to diagnose
PFJOA [29]. Nine studies used a combination of subject-
ive and objective information and radiographic evidence
of PFJOA to make the diagnosis. Two based their assess-
ments on NICE clinical guidelines which stipulated that
imaging was not required for a clinical diagnosis of OA.
Nine studies used pain on stair climbing and rising
from a chair as a subjective criterion and four studies
also included pain on a squatting manoeuvre. Tan et al.
[22, 23] used NICE clinical guidelines which included
the criteria of anterior knee pain greater than 30/100cm
on the VAS during stair ambulation, sitting or squatting.
These activities are known to load the PFJ and to be
Fig. 3 KOOS PAIN/WOMAC pain brace trials versus controls
Fig. 4 VAS multimodal physiotherapy versus controls
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painful activities in PFJOA. Quilty et al. [21] did not use
any specific subjective indicators commonly used to
diagnose PFJOA. Their participants were identified by
chronic knee pain and radiographic evidence of PFJOA.
Pain reproduced when palpating the patella facets was
used as an objective assessment of PFJOA in 4 of the
studies [13–16]. Although not validated as a diagnostic
test there is general consensus within the literature that
this technique is useful in characterising PFJOA [29, 30].
Using the same outcome measure allows comparison
of a treatment modality’s effectiveness across the differ-
ent trials. Although a pain VAS was used in 9 out of the
11 studies, each study recorded the pain score differ-
ently, namely performing a single leg squat [16], during
an aggravating activity [17, 22], average pain in past
week [19], average pain during the past month [21] and
average pain during a patient nominated aggravating ac-
tivity [13]. Additionally, studies had different time points
for assessment.
Four good quality studies examined the effect of bra-
cing in participants with PFJOA, though three of these
were based on data from a single trial. All these four
studies used the Bioskin Q brace which means the re-
sults are only applicable to this specific brace and cannot
be generalised to all knee braces. Hunter et al. [19]
found no significant treatment differences between
wearing a brace with a strap compared to a group wear-
ing a brace without a strap for an average of over 4 and
less than 5 h a day. Participant preference dictated
whether the patella strap was used. Conversely, Calla-
ghan et al. [13] noted a clinically and statistically signifi-
cant reduction in pain after wearing a brace compared
to a no-brace control group for an average of 7.4 h daily
for 6 weeks. The difference in daily time wearing the
brace and the absence of a no-brace control group in
Hunter et al. [19], and the different VAS questions used
in the studies may potentially explain these two trials’
differing results.
Patellar taping is a well-established intervention for
non-arthritic patellofemoral pain (PFP) or anterior knee
pain [31]. It is inexpensive, and after instruction by a
clinician, is self-applied by patients. Its mechanism is still
unclear, but reviews have reported its pain reducing ef-
fects in PFP [32–34]. Cushnaghan et al. [18] were the
first to study taping for PFJOA in their small (n=14)
crossover trial of three different forms of patellar taping.
Since then, there has been only one other study [16] of
14 participants on efficacy of taping for PFJOA. This
good quality study found a significant immediate reduc-
tion in pain on the VAS (−15.3mm). As taping is known
to loosen over time, it is unknown whether this effect
would continue in the medium or longer term. The two
good quality multimodal intervention studies delivered
by physiotherapists [16, 21] included a patellar taping
component but due to the combined approach the iso-
lated effects of the taping modality cannot be extrapo-
lated. Further, high-quality studies assessing longer-term
effects of taping are required.
Owing to the multi-factorial nature of painful PFJOA,
a combination of treatment modalities is often selected
to address the different dimensions of pain and dysfunc-
tion. Overall, there was evidence of a reduction in pain
among those randomised to a multimodal intervention
but no significant improvement in self-reported physical
function at 3 months [21] and at 5 months [17]. How-
ever, it is unclear whether participants had continued
with their exercise programme once the treatment ses-
sions had ceased and this may explain the lack of im-
provement in the long-term results. Additionally,
Crossley et al. [17] had a high dropout rate of 21% at the
9-month follow-up.
The results of the review highlight the lack of stand-
ardisation in clinical trials of PFJOA. In order to advance
our understanding of treatment response in this area,
clinical markers and objective tests to diagnose PFJOA
should be standardised. Additionally, there should be a
consensus on the tool used to score PFJOA on radio-
graphs. Due to the multi-factorial nature of PFJOA, fur-
ther research is required to examine the effect of
targeted physiotherapy interventions and where possible,
methodologies and outcome measures should be stan-
dardised. The same validated outcome measures should
be used across these clinical trials in order to allow com-
parisons of the treatment modalities. Long-term effects
should also be examined.
Limitations
There were some limitations to our review. The eleven
randomised clinical trials were of poor, moderate and
good quality for taping, bracing and foot orthotics.
There were none of excellent quality. One major limita-
tion in all the trials was the lack of blinding of the thera-
pists delivering the treatment, and only three trials were
able to blind the participants to treatment allocation. In
the eight other studies, it is likely participants were able
to distinguish between the interventions. The assessors
were blinded to group allocation in seven out of the
eleven studies which would mitigate against, though not
exclude the possibility of bias. The included papers were
in the English language only; therefore, studies published
in other languages may have been missed. This review
has not been registered online.
Conclusion
There was a relative paucity of trials studying the effect
of a biomechanical device therapy in patients with symp-
tomatic PFJOA. There is some good quality evidence
that a combined physiotherapy approach significantly
Callaghan et al. Systematic Reviews          (2021) 10:173 Page 11 of 13
reduces short-term pain in those with PFJOA. Long-
term effects of all interventions are still unknown, which
indicates the need for further research to determine the
longer term impact of all biomechanical devices on out-
comes in symptomatic PFJOA.
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